108 related articles for article (PubMed ID: 37493178)
1. Value of Adherence to Posttreatment Follow-Up Guidelines for Head and Neck Squamous Cell Carcinoma.
Stone A; Liu J; Lin J; Schiff BA; Ow TJ; Mehta V; Smith RV
Laryngoscope; 2024 Feb; 134(2):708-716. PubMed ID: 37493178
[TBL] [Abstract][Full Text] [Related]
2. Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Masroor F; Corpman D; Carpenter DM; Ritterman Weintraub M; Cheung KHN; Wang KH
JAMA Otolaryngol Head Neck Surg; 2019 Oct; 145(10):903-908. PubMed ID: 31393552
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
[TBL] [Abstract][Full Text] [Related]
4. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
Graboyes EM; Garrett-Mayer E; Sharma AK; Lentsch EJ; Day TA
Cancer; 2017 Jul; 123(14):2651-2660. PubMed ID: 28241092
[TBL] [Abstract][Full Text] [Related]
5. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
[TBL] [Abstract][Full Text] [Related]
6. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
7. Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
Cohen O; Brauer PR; Judson BL; Burtness BA; Earles J; Mehra S
Oral Oncol; 2022 Feb; 125():105694. PubMed ID: 34971883
[TBL] [Abstract][Full Text] [Related]
8. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
9. Association between adherence to posttreatment National Comprehensive Cancer Network (NCCN) surveillance guidelines and detection of recurrent uterine cancer.
Mayer CM; O'Connor RM; Do AT; Cerda VR; Wang SM; Scott ME; Li AJ; Rimel BJ; Manuel MR; Taylor KN; Kim KH
Gynecol Oncol; 2024 Feb; 181():8-11. PubMed ID: 38096674
[TBL] [Abstract][Full Text] [Related]
10. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
11. Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
Tam S; Nurgalieva Z; Weber RS; Lewis CM
Head Neck; 2019 Nov; 41(11):3960-3969. PubMed ID: 31497912
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
13. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data.
John A; Yang B; Shah R
Adv Ther; 2021 Mar; 38(3):1552-1566. PubMed ID: 33537872
[TBL] [Abstract][Full Text] [Related]
15. Risk of Disease Recurrence and Mortality Varies by Type of Fat Consumed before Cancer Treatment in a Longitudinal Cohort of Head and Neck Squamous Cell Carcinoma Patients.
Taha HM; Rozek LS; Chen X; Li Z; Zarins KR; Slade AN; Wolf GT; Arthur AE
J Nutr; 2022 May; 152(5):1298-1305. PubMed ID: 35170737
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Outcomes in Head and Neck Sarcomatoid Squamous Cell Carcinoma: The Cleveland Clinic Experience.
Mingo KM; Derakhshan A; Abdullah N; Chute DJ; Koyfman SA; Lamarre ED; Burkey BB
Ann Otol Rhinol Laryngol; 2021 Jul; 130(7):818-824. PubMed ID: 33269613
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of First Posttreatment Imaging Using Standardized Reporting in Head and Neck Cancer.
Hsu D; Chokshi FH; Hudgins PA; Kundu S; Beitler JJ; Patel MR; Aiken AH
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):978-985. PubMed ID: 31331239
[TBL] [Abstract][Full Text] [Related]
18. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
[TBL] [Abstract][Full Text] [Related]
19. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
[TBL] [Abstract][Full Text] [Related]
20. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
